Venomics AI Secures $2.7 Million in Pre-Seed Funding for Drug Discovery
Bio-tech startup Venomics AI has successfully raised $2.7 million in a pre-seed funding round. This capital infusion is earmarked to advance the company's research and development in venom-based drug discovery. The funding round was reportedly led by Speciale Invest and South Park Commons. Multiple media outlets, including BioSpectrum India, SMEStreet, Entrackr, and BW Disrupt, have confirmed the funding amount and its stated purpose. The consistent reporting across various sources suggests the information originated from a company announcement.
4 articles from 4 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
4 outlets covered “Venomics AI Secures $2.7 Million in Pre-Seed Funding for Drug Discovery”. All of them report the following:
- Venomics AI raised funding
- Funding for venom-based drug discovery
- Venomics AI is a bio-tech startup
- The funding is a pre-seed round
Which figures do outlets report differently?
1 figure in this story is reported with conflicting values:
Which outlets covered this?
All 4 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.